Active Stocks
Thu Apr 25 2024 15:57:40
  1. Kotak Mahindra Bank share price
  2. 1,643.00 -10.85%
  1. Tata Steel share price
  2. 167.60 1.27%
  1. State Bank Of India share price
  2. 812.60 5.10%
  1. Axis Bank share price
  2. 1,127.35 5.98%
  1. Power Grid Corporation Of India share price
  2. 292.60 0.71%
Business News/ Companies / GlaxoSmithKline, Apotex sue Lupin over generic Paxil drug
BackBack

GlaxoSmithKline, Apotex sue Lupin over generic Paxil drug

SmithKline Beecham Ltd claims Lupin is infringing a US patent for Paxil and should pay damages if the generic product is brought to market

Lupin is making ‘substantial preparation in the US’ to sell the copies, which indicates ‘a refusal to change the course of their actions,’ according to the complaint. Photo: Ramesh Pathania/MintPremium
Lupin is making ‘substantial preparation in the US’ to sell the copies, which indicates ‘a refusal to change the course of their actions,’ according to the complaint. Photo: Ramesh Pathania/Mint

Wilmington, Delaware: A unit of GlaxoSmithKline Plc, the UK’s largest drugmaker, joined with Canadian business partner Apotex Inc. to sue Indian generic pharmaceutical firm Lupin Ltd over plans to market copies of the antidepressant Paxil.

SmithKline Beecham Ltd claims Lupin is infringing a US patent for Paxil and should pay damages if the generic product is brought to market, according to a complaint filed Monday in federal court in Wilmington, Delaware.

Lupin is making “substantial preparation in the US" to sell the copies, which indicates “a refusal to change the course of their actions," according to the complaint. Bloomberg

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 05 May 2015, 10:20 PM IST
Next Story footLogo
Recommended For You